Splice launched its new generative AI tools to customize human-made samples — and musicians get paid with every AI use.
Rather than representing a distinct gene product, this peptide arises from alternative splicing events within the IGF-1 gene locus, leading to a unique E-domain sequence with properties that diverge f ...
Music creation platform Splice has launched a new suite of AI-powered tools – and says original sample creators will be ...
Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio ...
Researchers at the University of Trento have developed a CRISPR-based adenine base editing therapy that repaired the ...
Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in ...
Researchers developed STRIPE, a targeted long-read RNA sequencing tool that identifies disease-causing variants missed by ...
A breakthrough in genetics reveals how spines first appeared, changing what we know about the evolution of complex species.
SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...
New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...